Thyrocare Technologies Ltd.
| BSE: 539871 | Sector: Health care |
| NSE: THYROCARE | ISIN Code: INE594H01019 |
| BSE 12:00 | 28 Jun | 634.35 |
5.40 (0.86%) |
OPEN
633.40 |
HIGH
637.55 |
LOW
632.85 |
| NSE 11:49 | 28 Jun | 634.90 |
5.40 (0.86%) |
OPEN
634.95 |
HIGH
638.05 |
LOW
630.95 |
| OPEN | 633.40 |
| PREVIOUS CLOSE | 628.95 |
| VOLUME | 1803 |
| 52-Week high | 1445.10 |
| 52-Week low | 620.25 |
| P/E | 22.07 |
| Mkt Cap.(Rs cr) | 3,356 |
| Buy Price | 634.05 |
| Buy Qty | 27.00 |
| Sell Price | 635.30 |
| Sell Qty | 2.00 |
Thyrocare Technologies Ltd. (THYROCARE) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 513.00 | -8.30 | -1.59 | 15823.68 |
| Cipla | 927.95 | -4.30 | -0.46 | 13900.58 |
| Dr Reddy's Labs | 4335.30 | 18.15 | 0.42 | 13349.10 |
| Sun Pharma.Inds. | 828.90 | -7.05 | -0.84 | 12803.21 |
| Lupin | 632.65 | 2.75 | 0.44 | 11055.93 |
| Apollo Hospitals | 3805.00 | 11.65 | 0.31 | 9153.00 |
| Zydus Lifesci. | 353.95 | 0.05 | 0.01 | 7790.40 |
| Glenmark Pharma. | 385.40 | -1.05 | -0.27 | 7567.93 |
| Alkem Lab | 2992.55 | -39.85 | -1.31 | 7219.68 |
| Divi's Lab. | 3602.00 | -71.50 | -1.95 | 6798.61 |
| Torrent Pharma. | 2837.85 | -22.75 | -0.80 | 6450.83 |
| Ipca Labs. | 909.30 | -2.55 | -0.28 | 5114.11 |
| Alembic Pharma | 743.15 | -5.80 | -0.77 | 5051.44 |
| Laurus Labs | 465.40 | -1.65 | -0.35 | 4707.04 |
| Abbott India | 17881.00 | -110.20 | -0.61 | 4310.02 |
| Gland Pharma | 2637.00 | -21.60 | -0.81 | 3462.88 |
| Glaxosmi. Pharma | 1495.10 | -4.05 | -0.27 | 3193.74 |
| Granules India | 275.65 | 7.75 | 2.89 | 3134.98 |
| Sanofi India | 6404.85 | -31.90 | -0.50 | 2956.60 |
| Ajanta Pharma | 1258.75 | -5.20 | -0.41 | 2718.59 |
Quick Links for Thyrocare Technologies:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
